{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Tivozanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tivozanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tivozanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "tivozanib",
    "trial_2_text": "Tivozanib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Tivozanib Supplement: 60 participants will take Tivozanib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Tivozanib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Tivozanib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.42612871527671814,
      "78": 0.4149518311023712,
      "189": 0.2664770781993866,
      "123": 0.24083973467350006,
      "20": 0.23661980032920837,
      "188": 0.23449404537677765,
      "17": 0.226667582988739,
      "67": 0.2168039083480835,
      "37": 0.19740286469459534,
      "228": 0.19429366290569305,
      "9": 0.19310405850410461,
      "64": 0.1914784014225006,
      "243": 0.17507822811603546,
      "173": 0.17449402809143066,
      "21": 0.17359356582164764,
      "46": 0.1665230691432953,
      "77": 0.16111300885677338,
      "177": 0.15307290852069855,
      "200": 0.1480138748884201,
      "104": 0.14109250903129578,
      "68": 0.1306544542312622,
      "350": 0.1286124587059021,
      "257": 0.1248912438750267,
      "339": 0.12425325810909271,
      "79": 0.12382248789072037,
      "5": 0.11885741353034973,
      "72": 0.11882589012384415,
      "14": 0.11662398278713226,
      "49": 0.11410930752754211,
      "239": 0.11386384069919586,
      "29": 0.11311597377061844,
      "2": 0.1089719906449318,
      "18": 0.10886137932538986,
      "191": 0.10860611498355865,
      "193": 0.1059778481721878,
      "261": 0.10581684857606888,
      "101": 0.1033514067530632,
      "76": 0.10174372047185898,
      "85": 0.10168333351612091,
      "130": 0.09817220270633698,
      "126": 0.09810081869363785,
      "114": 0.09653348475694656,
      "204": 0.094915971159935,
      "131": 0.09488590061664581,
      "27": 0.09377722442150116,
      "180": 0.09199544787406921,
      "28": 0.09119381755590439,
      "454": 0.0908525139093399,
      "116": 0.09083038568496704,
      "382": 0.0893300473690033,
      "4": 0.0885506421327591,
      "136": 0.0879756510257721,
      "179": 0.0869349017739296,
      "86": 0.08627373725175858,
      "82": 0.08531630784273148,
      "234": 0.08440032601356506,
      "102": 0.08227511495351791,
      "147": 0.08177495002746582,
      "355": 0.08173178136348724,
      "396": 0.08095771074295044,
      "122": 0.07970653474330902,
      "35": 0.07870641350746155,
      "30": 0.07822757214307785,
      "337": 0.076817587018013,
      "98": 0.07679294049739838,
      "36": 0.07536205649375916,
      "186": 0.07502507418394089,
      "69": 0.07450448721647263,
      "139": 0.07413320243358612,
      "212": 0.07342753559350967,
      "194": 0.07307286560535431,
      "33": 0.07287751883268356,
      "341": 0.0706259235739708,
      "422": 0.06966099888086319,
      "288": 0.06938491016626358,
      "97": 0.06886480748653412,
      "253": 0.06791002303361893,
      "38": 0.06782010197639465,
      "100": 0.0670773983001709,
      "249": 0.06607743352651596,
      "124": 0.06570100039243698,
      "151": 0.06538472324609756,
      "221": 0.06531336903572083,
      "132": 0.06487417221069336,
      "61": 0.06415681540966034,
      "297": 0.06377071142196655,
      "371": 0.06369201093912125,
      "211": 0.06320568174123764,
      "352": 0.06313278526067734,
      "282": 0.06272802501916885,
      "286": 0.06252380460500717,
      "276": 0.062369205057621,
      "218": 0.06228456646203995,
      "92": 0.06181972101330757,
      "83": 0.06118536740541458,
      "508": 0.059569429606199265,
      "441": 0.0591060072183609,
      "400": 0.058817047625780106,
      "144": 0.05785096809267998,
      "535": 0.057538438588380814
    },
    "trial_2_ae": {
      "87": 0.42612871527671814,
      "78": 0.4149518311023712,
      "189": 0.2664770781993866,
      "123": 0.24083973467350006,
      "20": 0.23661980032920837,
      "188": 0.23449404537677765,
      "17": 0.226667582988739,
      "67": 0.2168039083480835,
      "37": 0.19740286469459534,
      "228": 0.19429366290569305,
      "9": 0.19310405850410461,
      "64": 0.1914784014225006,
      "243": 0.17507822811603546,
      "173": 0.17449402809143066,
      "21": 0.17359356582164764,
      "46": 0.1665230691432953,
      "77": 0.16111300885677338,
      "177": 0.15307290852069855,
      "200": 0.1480138748884201,
      "104": 0.14109250903129578,
      "68": 0.1306544542312622,
      "350": 0.1286124587059021,
      "257": 0.1248912438750267,
      "339": 0.12425325810909271,
      "79": 0.12382248789072037,
      "5": 0.11885741353034973,
      "72": 0.11882589012384415,
      "14": 0.11662398278713226,
      "49": 0.11410930752754211,
      "239": 0.11386384069919586,
      "29": 0.11311597377061844,
      "2": 0.1089719906449318,
      "18": 0.10886137932538986,
      "191": 0.10860611498355865,
      "193": 0.1059778481721878,
      "261": 0.10581684857606888,
      "101": 0.1033514067530632,
      "76": 0.10174372047185898,
      "85": 0.10168333351612091,
      "130": 0.09817220270633698,
      "126": 0.09810081869363785,
      "114": 0.09653348475694656,
      "204": 0.094915971159935,
      "131": 0.09488590061664581,
      "27": 0.09377722442150116,
      "180": 0.09199544787406921,
      "28": 0.09119381755590439,
      "454": 0.0908525139093399,
      "116": 0.09083038568496704,
      "382": 0.0893300473690033,
      "4": 0.0885506421327591,
      "136": 0.0879756510257721,
      "179": 0.0869349017739296,
      "86": 0.08627373725175858,
      "82": 0.08531630784273148,
      "234": 0.08440032601356506,
      "102": 0.08227511495351791,
      "147": 0.08177495002746582,
      "355": 0.08173178136348724,
      "396": 0.08095771074295044,
      "122": 0.07970653474330902,
      "35": 0.07870641350746155,
      "30": 0.07822757214307785,
      "337": 0.076817587018013,
      "98": 0.07679294049739838,
      "36": 0.07536205649375916,
      "186": 0.07502507418394089,
      "69": 0.07450448721647263,
      "139": 0.07413320243358612,
      "212": 0.07342753559350967,
      "194": 0.07307286560535431,
      "33": 0.07287751883268356,
      "341": 0.0706259235739708,
      "422": 0.06966099888086319,
      "288": 0.06938491016626358,
      "97": 0.06886480748653412,
      "253": 0.06791002303361893,
      "38": 0.06782010197639465,
      "100": 0.0670773983001709,
      "249": 0.06607743352651596,
      "124": 0.06570100039243698,
      "151": 0.06538472324609756,
      "221": 0.06531336903572083,
      "132": 0.06487417221069336,
      "61": 0.06415681540966034,
      "297": 0.06377071142196655,
      "371": 0.06369201093912125,
      "211": 0.06320568174123764,
      "352": 0.06313278526067734,
      "282": 0.06272802501916885,
      "286": 0.06252380460500717,
      "276": 0.062369205057621,
      "218": 0.06228456646203995,
      "92": 0.06181972101330757,
      "83": 0.06118536740541458,
      "508": 0.059569429606199265,
      "441": 0.0591060072183609,
      "400": 0.058817047625780106,
      "144": 0.05785096809267998,
      "535": 0.057538438588380814
    }
  },
  "safety": {
    "trial_1_safety": 0.3089759945869446,
    "trial_2_safety": 0.3089759945869446
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47802624106407166
  }
}